Invictus RG’s Colgate-Palmolive CL Stock Holding History

Invictus RG’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-1,871	Closed	-$122K	–	713
2016 Q4	$122K	Buy	+1,871	New	+$128K	0.08%	389
2016 Q3	–	Sell	-203	Closed	-$15K	–	676
2016 Q2	$15K	Buy	+203	New	+$14.5K	0.02%	457

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Invictus RG's CL Position: Q1 2017 in Review

Invictus RG sold out of Colgate-Palmolive (CL) in Q1 2017, closing a stake of 1,871 shares — an estimated $122K sold.

Invictus RG first reported a position in CL in Q2 2016 and held it in 2 quarters. The position peaked at $122K in Q4 2016. 1,365 funds tracked by Wall St. Rank hold CL as of Q1 2017.

Invictus RG reported no remaining Colgate-Palmolive position as of Q1 2017 after selling out during the quarter.
Invictus RG sold 1,871 Colgate-Palmolive shares in Q1 2017, an estimated $122K.
Invictus RG first reported a position in Colgate-Palmolive in Q2 2016 and held it in 2 quarters.
Invictus RG's Colgate-Palmolive position peaked at $122K in Q4 2016.
1,365 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2017.

Based on Invictus RG's 13F filing for Q1 2017, filed 12 May 2017.